Indication
Chimera
1 clinical trial
2 products
2 drugs
Clinical trial
Delayed Tolerance Through Mixed ChimerismStatus: Recruiting, Estimated PCD: 2028-12-01
Product
FludarabineDrug
cyclophosphamideDrug
VarlilumabProduct
Siplizumab1 clinical trial
2 products
2 drugs